Search Results - Qiu‐Xu Teng

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Understanding and targeting resistance mechanisms in cancer

    Understanding and targeting resistance mechanisms in cancer by Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, John N.D. Wurpel, Leli Zeng, Yihang Pan, Zhe‐Sheng Chen

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo

    Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo by Albert A. De Vera, Pranav Gupta, Zi‐Ning Lei, Dan Liao, Silpa Narayanan, Qiu‐Xu Teng, Sandra E. Reznik, Zhe‐Sheng Chen

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells

    Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells by Wei Zhang, Yingfang Fan, Chao‐Yun Cai, Jing‐Quan Wang, Qiu‐Xu Teng, Zi‐Ning Lei, Leli Zeng, Pranav Gupta, Zhe‐Sheng Chen

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Signaling pathways and therapeutic interventions in gastric cancer

    Signaling pathways and therapeutic interventions in gastric cancer by Zi‐Ning Lei, Qiu‐Xu Teng, Tian Qin, Wei Chen, Yuhao Xie, Kaiming Wu, Qianlin Zeng, Leli Zeng, Yihang Pan, Zhe‐Sheng Chen, Yulong He

    Published 2022
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis

    The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis by Zi‐Ning Lei, Qiu-Xu Teng, Jagadish Koya, Yangruiyu Liu, Zizhou Chen, Leli Zeng, Zhe‐Sheng Chen, Shuo Fang, Jinxiang Wang, Yuchen Liu, Yihang Pan

    Published 2024
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters

    VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters by Ning Ji, Yuqi Yang, Chao‐Yun Cai, Zi‐Ning Lei, Jing‐Quan Wang, Pranav Gupta, Qiu‐Xu Teng, Zhe‐Sheng Chen, Dexin Kong, Dong‐Hua Yang

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells

    Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells by Jing‐Quan Wang, Jonathan Y. Li, Qiu‐Xu Teng, Zi‐Ning Lei, Ning Ji, Qingbin Cui, Leli Zeng, Yihang Pan, Dong‐Hua Yang, Zhe‐Sheng Chen

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells

    Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells by Weiguo Feng, Meng Zhang, Zhuo‐Xun Wu, Jing‐Quan Wang, Xing-Duo Dong, Yuqi Yang, Qiu‐Xu Teng, Xuan-Yu Chen, Qingbin Cui, Dong‐Hua Yang

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro

    Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro by Yuqi Yang, Ning Ji, Qiu‐Xu Teng, Chao‐Yun Cai, Jing‐Quan Wang, Zhuo‐Xun Wu, Zi‐Ning Lei, Sabrina Lusvarghi, Suresh V. Ambudkar, Zhe‐Sheng Chen

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance

    Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance by Zhuo‐Xun Wu, Yuqi Yang, Qiu‐Xu Teng, Jing‐Quan Wang, Zi‐Ning Lei, Jing-Qiu Wang, Sabrina Lusvarghi, Suresh V. Ambudkar, Dong‐Hua Yang, Zhe‐Sheng Chen

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor

    Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor by Saiqi Wang, Qiu‐Xu Teng, Shuai Wang, Zi‐Ning Lei, Huihui Hu, Huifang Lv, Beibei Chen, Jianzheng Wang, Xiaojing Shi, Weifeng Xu, Hong‐Min Liu, Xiaobing Chen, Zhe‐Sheng Chen, Bin Yu

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: